BBWI Q2 2026: EPS of $0.62 Beats $0.25 Estimate as Operating Income Jumps 37.6%
Alpha Stocks Insight Staff
Independent stock news and analysis covering NASDAQ and NYSE markets.
Bath & Body Works posted adjusted EPS of $0.62 vs. a $0.25 estimate, but $80M in tariff refunds cloud the profit quality as analysts trim price targets.
Bath & Body Works (NYSE: BBWI) reported second-quarter 2026 results for the period ended August 1, 2026, with adjusted EPS of $0.62 and GAAP EPS of $0.58, both exceeding the company's own guidance and handily topping the $0.25 consensus estimate. Net sales of $1.514 billion came in below the prior-year quarter's $1.549 billion, a 2.3% year-over-year decline, though bottom-line results improved substantially.
Q2 2026 Results
- Net sales: $1.514 billion, down 2.3% year-over-year from $1.549 billion in Q2 2025
- GAAP EPS: $0.58, up from $0.30 in Q2 2025; adjusted EPS: $0.62, up from $0.37 in Q2 2025
- GAAP operating income: $216 million, up 37.6% year-over-year; GAAP operating margin expanded 4.2 percentage points to 14.3%
- Direct (U.S. and Canada) net sales: $275 million, up 3.0% year-over-year, marking the first direct net sales growth since 2021
- International and Other net sales: $108 million, up 24.9% year-over-year; partner-operated international store count reached 596, up from 573 at fiscal year-start
What Drove the Results
Adjusted EPS of $0.62 beat the $0.25 consensus estimate by 148.0%. Cost of Goods Sold, Buying and Occupancy declined from $909 million to $822 million year-over-year, and General, Administrative and Store Operating Expenses fell from $483 million to $476 million, driving the operating margin improvement despite the top-line decline. Critically, results included approximately $80 million in tariff refunds received during the quarter; excluding that benefit, adjusted EPS would have been $0.31, roughly in line with the prior-year adjusted figure of $0.37.
GAAP net income of $118 million compared to $64 million a year ago, an 84.4% increase. The difference between GAAP and adjusted net income reflects $9 million in pre-tax business transformation costs ($7 million after tax), producing a $7 million gap between reported and adjusted figures for the quarter.
Year-to-date operating cash flow reached $316 million, up from $145 million in the same period last year. Capital expenditures for the first half totaled $98 million versus $93 million a year ago.
Guidance Raised
Bath & Body Works raised its full-year 2026 GAAP EPS guidance to a range of $3.13 to $3.33, up from the prior-year actual of $3.11, and its full-year adjusted EPS guidance to $2.60 to $2.80, compared to $3.21 in fiscal 2025. Full-year net sales guidance was narrowed to a decline of 4% to 2.5% versus $7.291 billion in fiscal 2025. The company projected full-year free cash flow of approximately $650 million, supported by forecasted capital expenditures of $240 million. No share repurchases are assumed in the outlook. For Q3 2026, the company guided to GAAP EPS of $0.05 to $0.10 and adjusted EPS of $0.07 to $0.12, compared to adjusted EPS of $0.35 in Q3 2025, with net sales expected to decline 5% to 2.5% versus $1.594 billion in the prior-year quarter.
Wall Street View
Several analyst firms trimmed their price targets following the results. Baird analyst Mark Altschwager maintained a Neutral rating and lowered his target from $25 to $23. Barclays analyst Adrienne Yih maintained an Equal-Weight rating and cut her target from $23 to $22. UBS analyst Jay Sole maintained a Neutral rating and reduced his target from $19 to $17. Wells Fargo analyst Ike Boruchow maintained an Overweight rating, lowering his target from $26 to $24. Shares fell 1.32% on Thursday, August 27, while the S&P 500 gained 0.66%.
Investor Takeaway
The Q2 beat is real but partially inflated: stripping out the $80 million in one-time tariff refunds brings adjusted EPS to $0.31, a figure that more accurately reflects the business's underlying trajectory amid continued store-level sales pressure. The Q3 guidance of $0.07 to $0.12 adjusted EPS versus $0.35 a year ago indicates a material step-down ahead, and the full-year free cash flow target of $650 million will be the key metric for investors assessing whether the company's cost discipline can offset ongoing top-line softness through fiscal year-end.
Editorial oversight by Teodora Hristova, Founder & Editor
Related Coverage
- Bath & Body Works Moves to Redeem $250M in Senior Notes, Targeting August PayoffMonday, July 20, 2026
- Dollar General (NYSE: DG) Posts Q2 EPS of $2.48, Up 33.3% YoY, Raises Full-Year GuidanceDG · Friday, August 28, 2026
- Autodesk (ADSK) Q2 FY2027: Revenue Up 16%, Raises Full-Year Guidance After MaintainX DealADSK · Friday, August 28, 2026
- Ulta Beauty (NASDAQ: ULTA) Beats Q2 2026 With $6.55 EPS, Raises Full-Year GuidanceULTA · Friday, August 28, 2026
- HP Inc. (NYSE: HPQ) Posts Record Q3 Revenue of $15.7B, Raises Full-Year EPS GuidanceHPQ · Wednesday, August 26, 2026
Important Legal Disclaimer
This is for informational purposes only and is not financial, investment, or tax advice. Past performance is no guarantee of future results. We are not licensed advisors. For Swiss residents: This does not constitute a public offer under FINSA. For EU residents: Not MiFID II compliant advice. For US residents: Not SEC-registered advice. Always consult a qualified professional. Investing involves risk of loss.
Affiliate disclosure: This site may contain affiliate links to brokerage platforms. If you open an account through one of our links, we may earn a commission at no additional cost to you. Affiliate relationships do not influence our editorial content or stock coverage decisions.
